These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2036417)
21. Solution structure of murine epidermal growth factor determined by NMR spectroscopy and refined by energy minimization with restraints. Montelione GT; Wüthrich K; Burgess AW; Nice EC; Wagner G; Gibson KD; Scheraga HA Biochemistry; 1992 Jan; 31(1):236-49. PubMed ID: 1731873 [TBL] [Abstract][Full Text] [Related]
22. Three-dimensional structure of human [113Cd7]metallothionein-2 in solution determined by nuclear magnetic resonance spectroscopy. Messerle BA; Schäffer A; Vasák M; Kägi JH; Wüthrich K J Mol Biol; 1990 Aug; 214(3):765-79. PubMed ID: 2388267 [TBL] [Abstract][Full Text] [Related]
23. Determination of the solution structure of Apo calbindin D9k by NMR spectroscopy. Skelton NJ; Kördel J; Chazin WJ J Mol Biol; 1995 Jun; 249(2):441-62. PubMed ID: 7783203 [TBL] [Abstract][Full Text] [Related]
24. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. DiMarchi RD; Chance RE; Long HB; Shields JE; Slieker LJ Horm Res; 1994; 41 Suppl 2():93-6. PubMed ID: 8088710 [TBL] [Abstract][Full Text] [Related]
26. The sequence determinant causing different folding behaviors of insulin and insulin-like growth factor-1. Huang QL; Zhao J; Tang YH; Shao SQ; Xu GJ; Feng YM Biochemistry; 2007 Jan; 46(1):218-24. PubMed ID: 17198392 [TBL] [Abstract][Full Text] [Related]
27. The high resolution solution structure of the insulin monomer determined by NMR. Kaarsholm NC; Ludvigsen S Receptor; 1995; 5(1):1-8. PubMed ID: 7613479 [TBL] [Abstract][Full Text] [Related]
28. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition. Hua QX; Weiss MA Biochemistry; 1991 Jun; 30(22):5505-15. PubMed ID: 2036420 [TBL] [Abstract][Full Text] [Related]
29. Solution structure of an engineered insulin monomer at neutral pH. Olsen HB; Ludvigsen S; Kaarsholm NC Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419 [TBL] [Abstract][Full Text] [Related]
30. The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain. Guo ZY; Shen L; Feng YM Biochemistry; 2002 Feb; 41(5):1556-67. PubMed ID: 11814349 [TBL] [Abstract][Full Text] [Related]
31. Refinement of the solution structure of the DNA decamer 5'd(CTGGATCCAG)2: combined use of nuclear magnetic resonance and restrained molecular dynamics. Nilges M; Clore GM; Gronenborn AM; Piel N; McLaughlin LW Biochemistry; 1987 Jun; 26(12):3734-44. PubMed ID: 3651408 [TBL] [Abstract][Full Text] [Related]
32. The in vitro oxidative folding of the insulin superfamily. Guo ZY; Qiao ZS; Feng YM Antioxid Redox Signal; 2008 Jan; 10(1):127-39. PubMed ID: 18004974 [TBL] [Abstract][Full Text] [Related]
33. Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis. Hua QX; Kochoyan M; Weiss MA Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2379-83. PubMed ID: 1549601 [TBL] [Abstract][Full Text] [Related]
34. Complex with a phage display-derived peptide provides insight into the function of insulin-like growth factor I. Schaffer ML; Deshayes K; Nakamura G; Sidhu S; Skelton NJ Biochemistry; 2003 Aug; 42(31):9324-34. PubMed ID: 12899619 [TBL] [Abstract][Full Text] [Related]
35. Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains. Marti DN; Schaller J; Llinás M Biochemistry; 1999 Nov; 38(48):15741-55. PubMed ID: 10625440 [TBL] [Abstract][Full Text] [Related]
36. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Sitar T; Popowicz GM; Siwanowicz I; Huber R; Holak TA Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13028-33. PubMed ID: 16924115 [TBL] [Abstract][Full Text] [Related]
37. Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition. Hua QX; Shoelson SE; Weiss MA Biochemistry; 1992 Dec; 31(47):11940-51. PubMed ID: 1445924 [TBL] [Abstract][Full Text] [Related]
38. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa. Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408 [TBL] [Abstract][Full Text] [Related]
39. Three-dimensional solution structure of bombyxin-II an insulin-like peptide of the silkmoth Bombyx mori: structural comparison with insulin and relaxin. Nagata K; Hatanaka H; Kohda D; Kataoka H; Nagasawa H; Isogai A; Ishizaki H; Suzuki A; Inagaki F J Mol Biol; 1995 Nov; 253(5):749-58. PubMed ID: 7473749 [TBL] [Abstract][Full Text] [Related]
40. The solution structure of human epidermal growth factor. Cooke RM; Wilkinson AJ; Baron M; Pastore A; Tappin MJ; Campbell ID; Gregory H; Sheard B Nature; 1987 May 28-Jun 3; 327(6120):339-41. PubMed ID: 3495735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]